| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| autologous anti-cd19car-4-1bb-cd3zeta-egfrt-expressing t lymphocytes | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] Malignant lymphoma lymphocytic intermediate differentiation diffuse[MeSHID:D020522] T-Lymphocyte[MeSHID:D013601] Chronic Lymphocytic Leukemia[MeSHID:D015451] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] |
NA | phase 1/2 | unknown |
| click here to return to the previous page | ||||||||